NPSP

NPS Pharmaceuticals, Inc. Press Releases

$27.24
*  
0.33
1.23%
Get NPSP Alerts
*Delayed - data as of Aug. 22, 2014  -  Find a broker to begin trading NPSP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

NPS Pharma Reports Second-Quarter 2014 Financial Results
8/6/2014 4:30:00 PM - Business Wire

NPS Pharma to Present at Upcoming Conferences
8/5/2014 8:10:00 AM - Business Wire

NPS Pharma Initiates Phase 2a Study of NPSP795 in Adult Patients with Autosomal Dominant Hypocalcemia (ADH)
8/4/2014 8:10:00 AM - Business Wire

NPS Pharma to Report Second Quarter 2014 Financial Results
7/29/2014 8:10:00 AM - Business Wire

PARADOX Findings Published in Endocrine Practice Describe High Burden of Illness in Patients with Hypoparathyroidism
7/24/2014 8:47:00 AM - Business Wire

FDA Approves Updated Labeling for Gattex® (Teduglutide [rDNA origin]) for Injection to Include Long-Term Data
6/30/2014 8:30:00 AM - Business Wire

Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma
6/27/2014 7:50:00 AM - PR Newswire

NPS Pharma Reports Change in Tentative Date of FDA Advisory Committee Review of Natpara® BLA to September 12 - PDUFA Date of October 24 Remains Unchanged
6/10/2014 8:30:00 AM - Business Wire

NPS Pharma to Present at Goldman Sachs Global Healthcare Conference
6/3/2014 4:10:00 PM - Business Wire

SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of NPS Pharmaceuticals, Inc. - NPSP
6/2/2014 12:34:00 PM - PR Newswire

Top Gainers at a Glance -- Research on NPS Pharma, Doral Financial, Retrophin, and Papa Murphy's Holdings
6/2/2014 5:30:00 AM - PR Newswire

NPS Pharma Introduces Emergency Resources Kit for Patients in Recognition of World Hypoparathyroidism Awareness Day
5/30/2014 8:30:00 AM - Business Wire

NPS Pharma Celebrates 20th Anniversary of Initial Public Offering with NASDAQ Opening Bell Ceremony
5/27/2014 8:30:00 AM - Business Wire